11/17/2022 0 Comments Cancer Registry Software Market Outlook, Key Financials, Segmental Revenue and Geographical Revenue till 2027Market Insights
Cancer registry software is a programmed tool of a directory that creates and maintains end-to-end reporting of cancer incidences. It is majorly used to get an overview of certain cases while investigating cancer and its causes. According to Market Research Future, the global cancer registry software market reached $56.4 Million in 2022 and is predicted to attain a CAGR of 10.7% during the forecast period, 2022-2027 Extraordinary breakthroughs and penetrations of science and technology are evolving radically and restructuring the practice of medicine. Aging population, growing middle spending abilities on healthcare, the burden of chronic disease is transforming the patient needs. However, these factors are stimulating new demands dedicated to innovation and access to advanced tools that deliver reliable patient data and comprehensive report of every stage in treatment. Novel technologies such as predictive modeling for medical procedures are set to flourish owing to growing investment in R&D activities in the field of clinical and molecular data. Growing trend of using data analytics to create reference case study for futuristic clinical operations is likely to propel the global cancer registry software market. Major Players Industry leaders are keenly focusing on the development of convenient and accessible solutions for handling critical data related to cancer. Some of the leading players contributing with their product and services include McKesson Corporation, Electronic Registry Systems, Inc., IBM, C/Net Solutions, Himagine Solutions Inc, Rocky Mountain Cancer Data Systems, Ordinal Data Inc, Conduent Inc, Elekta AB (PUB), and Onco, Inc. Market Segmentation The global Cancer Registry Software Market Share is broadly segmented based on the factor such as type, deployment model, database, functionality, and end-user. The type segment is bifurcated into standalone software and integrated software. Based on the deployment model, the global cancer registry software market is divided into on-premise and cloud-based. Similarly, the database type segment is classified into public and commercial. On the basis of functionality, the global cancer registry software market is segmented into product outcome evaluation, patient care management, medical research, clinical studies, and reporting to federal regulations. Moreover, the end-user segment is diversified into hospitals, government organizations, medical practitioners, pharmaceutical, research centers, medical device companies, and biotechnology. Regional Analysis Geographically, the Americas is expected to influence the global cancer registry software market owing to the growing focus on high-tech product development, growing investment for R&D in region. As per National Cancer Institute, approximately 1,735,350 new cases of cancer were registered in the US, in 2022. Europe ranks second after the Americas owing to funding availability and existence of robust research and academic institutes in the region. The European cancer registry software market is anticipated to register a considerable growth during the forecast period. Moreover, emerging pharmaceutical industry due to low manpower cost and favorable trade conditions in developing markets such as India and China are foreseen to speed up the growth of cancer registry software market in Asia Pacific. A growing number of cancer patients in these regions in contrast to the escalating population makes it mandatory to keep a track on every cancer patient and their diagnostic data. The Middle East & Africa has the least contribution in the global cancer registry software market and is anticipated to see a moderate growth owing to rising government initiatives for healthcare sectors. About US: Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street,5Th Floor, New York, New York 10013, United States of America
0 Comments
11/17/2022 0 Comments Closed System Drug Transfer Device Market Trend, Industry Overview, Competitive Analysis and Foreseen by 202711/17/2022 0 Comments Pharmacy Benefit Management Services Market Financial Overview, SWOT Analysis, Key Development and Forecasts Till 2027Pharmacy Benefit Management Services Market Overview:
Market Research Future (MRFR) has recently published a report, which reveals that the global Pharmacy Benefit Management Services Market Share is set to demonstrate a compound annual growth rate (CAGR) of 5.7% from 2022 to 2030. Pharmacy befits management services are gaining popularity in various healthcare markets across the world. These services assist customers in identification of best medical facilities. Moreover, these services allow insurance companies to improve service quality and streamline the processing procedure. The services also help in improving the communication in the healthcare network, which consists of drug companies, drug wholesalers, members, pharmacies, employers among other. They facilitate a process that can lead to the best possible outcomes with regards to reimbursement claims and other operations. At the same time, rising digitization, growing need for cutting-edge healthcare management solutions, increase global healthcare expenditure and growth of the healthcare sector in the developing world is providing an impetus to the global market for pharmacy benefit management services. Governments in developing countries are making stronger efforts to raise the standard of healthcare where, the healthcare insurance sector is expected to play an important. As more and more people become insured, importance of management services grows further. The data released by the Agency for healthcare research and quality (AHRQ) revealed that over 626 health systems were operating in the U.S. in 2016 under which more than 69 hospitals were covered. Global Pharmacy Benefit Management Services Market: Competition Analysis MRFR in its report has mentioned some of top-notch market players, which include CVS Health, Humana Pharmacy Solutions, McKesson Corporation, MeridianRx, Prime Therapeutics, Vidalink, Abarca health LLC., Magellan Rx Management, Sea Rainbow, Medimpact Healthcare, Express Scripts, and OptumRx (UnitedHealth). Global Pharmacy Benefit Management Services Market: Segmental Analysis The segmental analysis of the market has been conducted based on end-user, service and region. On the basis of end user, the market has been segmented into employers, drug manufacturers, healthcare providers and others. Based on service, the market has been segmented into specialty pharmacy services, drug formulary management, retail pharmacy services, benefit plan design and consultation and others. Global Pharmacy Benefit Management Services Market: Regional Analysis Americas is expected to lead the global market for pharmacy benefits management services during the assessment period. The market growth in the region is attributed to faster adoption of novel technologies, presence of a robust healthcare system, high healthcare expenditure and a vast pool insurance holder. As per the data released by American Hospital Association, in 2016 the total number of registered hospitals in the U.S. was over 5,500 of which 3000+ hospitals were located in urban areas and the rest were operating in rural areas. The Centers for Medicare & Medicaid Services revealed that healthcare spending crossed 3 trillion inn the U.S. The Europe pharmacy benefits management services market is also expected to remain highly attractive over the next couple of years. Factors such as presence of favourable reimbursement policies, growing patient pool, and fast uptake of advanced medical technologies are during the market growth in Europe. A survey conducted by the organization for Economic Co-operation and Development (OECD) revealed that per capita healthcare expenditure in Europe reached USD 4, 077 in 2017. Asia Pacific is anticipated to present attractive opportunities to market players in the forthcoming years. Growth of the healthcare sector in countries such as India and China is reflecting favourably on the market in the region. Moreover, rising awareness level about advanced healthcare management technologies, and increased healthcare penetration are some of the other factors creating market opportunities. The emerging economies in the region are making significant contribution to the market in term of revenue. About US: Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street,5Th Floor, New York, New York 10013, United States of America 11/17/2022 0 Comments Dental Lasers Market Key Manufactures Shares, Analysis and Forecasts Till 202711/17/2022 0 Comments Anti-Hypertensive Drugs Market Opportunities, Drivers, Manufacturers, Analysis and Forecasts Till 2027Market Scenario for Global Anti-Hypertensive Drugs Market:
Anti-hypertensive drugs are used to treat hypertension (high blood pressure). Hypertension is a state of chronic elevated arterial blood pressure at or greater than 140/90 mm Hg for adults. The global anti-hypertensive drugs market was valued at $32.2 billion in 2015, and is expected to reach $ 38.9 billion by 2027. Thus the antihypertensive medication market is expected to perform sluggish growth at a CAGR of 2.73% from 2022 to 2027. The constraints however are overwhelming and include patent expiries such as Actelion's Tracleer (2015), and United Therapeutic's Remodulin (2014). Other blockbuster’s such as Novartis's Diovan and Exforge, Sanofi Aventis's Avapro (2012) etc are also off-patent. Key Players for Global Anti-Hypertensive Drugs Market: Novartis AG, Daiichi Sankyo Company Limited, Acetelion Ltd, Boehringer Ingelheim, Sanofi S.A., Astra Zeneca plc, Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceuticals Company Limited, Pfizer Inc. Segments Global Anti-Hypertensive Drugs Market: Global AntiHypertensive Drugs Market Share has been segmented on the basis of pharmacological class, hypertension type, disease source and Region. Study Objectives Global Anti-Hypertensive Drugs Market: To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the global anti-hypertensive drugs market To provide insights about factors affecting the market growth To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. To provide country level analysis of the market with respect to the current market size and future prospective. To provide country level analysis of the market for segments and sub-segments. To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally. Regional Analysis Global Anti-Hypertensive Drugs Market: Globally North America is the largest market for global anti-hypertensive drugs. Europe is the second-largest market for global anti-hypertensive drugs. The near future market for anti-hypertensive drugs will be dominated by the developed regions with developing regions providing a supporting role only. However the developing regions market particularly Asia Pacific will be the fastest growing and is likely to be the key to the future. About US: Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street,5Th Floor, New York, New York 10013, United States of America 11/16/2022 0 Comments Retinal Implants Market Key Manufactures Shares, Analysis and Forecasts Till 2027Retinal Implants Market Overview:
Retinal implants have cropped up as breakthrough therapy in the treatment of visual impairment. The global retinal implants market is advancing at a rapid pace and is projected to reach a significant valuation in the forthcoming years, reveals Market Research Future (MRFR) in a recently published research report. The widespread prevalence of retinal disorders such as age-related macular degeneration and retinitis pigmentosa has generated considerable demand for retinal implants. Retinal implants have demonstrated significant restoration of vision in cases which were previously far off impossible to achieve. Growing popularity of minimally invasive surgical techniques is a crucial driver of the global retinal implants market. Retinal implants do not require much invasion and can be implanted with minimal incision which makes patients opt for them. The growth in the global retinal implants market can also be attributed to the rise in global geriatric population. The aged populace is more prone to visual impairment and acquiring retinal disorders such as age-related macular degeneration and induce high demand for diagnosis and treatment and consequently boost the growth of the global retinal implants market. The currently available retinal implants are partially successful in restoring vision and being updated continuously to prove fully effective. The recent years have also witnessed massive investment in R&D due to the massive market potential of retinal implants. In addition, various clinical trials are underway to develop advanced retinal implants. Approvals by FDA for retinal implants have witnessed an increase which has also added fuel to the growth of the market. Improving reimbursement scenario has resulted in the adoption of retinal implants as a treatment option and raising awareness regarding the availability of retinal implants has been a plus for the growth of the global retinal implants market. On the other hand, the Retinal Implants Market share might encounter few hurdles which might impede the growth of the market in the coming years. The dearth of skilled medical professionals with adequate knowledge about the product and complicated approval process of FDA approval can hinder the market growth. Other limiting factors include the high cost of retinal implants and risk of biocompatibility and unknown long-term efficacy of retinal implants. Retinal implants are still in the nascent stage, and there is a lot of speculations hovering around it which can hinder adoption. Competitive Landscape VisionCare, Inc., Bionic Vision Australia (BVA), Retina Implant AG, Visus Technology, Inc., Second Sight Medical Products, Inc., and Bionic Eye Technologies, Inc. are the eminent players in the global retinal implants market. Segmentation The global retinal implants market has been segmented based on disease indication, device type, and end user. On the basis of disease indication, the global retinal implants market has been segmented into age-related macular degeneration (AMD) and retinitis pigmentosa. Device type segmentation of the global retinal implants market includes retina implant alpha AMS, Argus II, implantable miniature telescope, and others. By end user, the global retinal implants market has been segmented into multi-specialty hospitals, ophthalmic clinics, and research institutes. Regional Analysis North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa are the key markets for retinal implants. North America is a significant market for retinal implants driven by easy availability, high awareness and favorable reimbursement scenario in the region. Presence of skilled medical professionals also aids the expansion of the North America retinal implants market. R&D activities and expanding clinical trials spur the growth of the market in Europe while the APAC market is driven by improving healthcare industry, higher affordability, and raising awareness. About US: Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street,5Th Floor, New York, New York 10013, United States of America 11/16/2022 0 Comments Assisted Reproductive Technology Market Shares Analysis, Key Development Strategies and Forecasts Till 2027Key Players
Some of the key players in the global assisted reproductive technology (ART) market are Cosmos Biomedical Limited, California Cryobank, Bloom IVF Centre, Cryolab Ltd., Parallabs, OvaScience, Anecova, Origio, Microm Ltd., Merck KGaA, Cooper Surgical, Inc, Ferring Pharmaceuticals, European Sperm Bank, Irvine Scientific and Hamilton Throne Ltd. Market Highlights The assisted reproductive technology (ART) market is expected to witness tremendous growth owing to the rising prevalence of infertility in males as well as females. Other key factors such as the growing obesity among population, rising ovulation disorders, change to sedentary lifestyle, socioeconomic factors like postponement of marriage due to unemployment and others, growing consumption of unhealthy diet, increasing occurrence of polycystic ovarian syndrome (PCOS), and increasing prevalence of breast or ovarian and endometrial cancer, increase in smoking and alcohol consumption are contributing towards the growth. However, factors such as, lower success rate, the high cost of artificial reproductive technology procedures, expensive treatments, raising ethical issues, chances of birth defects, the risk of prematurity and low birth weight in new-borns and side effects associated with hysterectomy procedures are expected to restrict the market growth during the forecast period. Segmentation The global Assisted Reproductive Technology Market Share is segmented on the basis of diagnosis, type, and end-user. The assisted reproductive technology market, by diagnosis, is categorized into ovulation testing, hysterosalpingography, ovarian reserve testing, genetic testing, other hormone testing and imaging tests. On the basis of type, the market is segmented into Ovulation Induction (OI), Artificial Insemination (AI), Donor Conception, In-Vitro Fertilization (IVF), Gamete Intrafallopian Transfer (GIFT), Intracytoplasmic Sperm Injection (ICSI), Preimplantation Genetic Diagnosis (PGD) and Surrogacy. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, gynecology centers, feminist health centers, and IVF Centers and others Regional Analysis Europe (UK, Belgium, France, and Netherlands) is the largest in the market owing to the increasing prevalence of obesity and growing healthcare expenditure. As per the World Health Organization, 23% of the women in Europe were obese in 2014. The Americas is the second largest the assisted reproductive technology (ART) market during the forecast period. The increasing occurrence of ovarian cancer drives the market in this region. The American Cancer Society estimated that in 2018, 22,240 women are likely to be diagnosed with ovarian cancer. This is expected to influence the market growth during the forecast period. Asia-Pacific was projected to be the fastest growing region for the global assisted reproductive technology (ART) market in 2017. The market is expected to witness growth owing to the rising prevalence of diabetes in women, changing lifestyle, and growing obesity within the female population. According to the Virtus Health 2018, infertility affects one in six Australian couples of the reproductive age. This is expected to provide favorable backgrounds for the market to grow. The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income. About US: Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street,5Th Floor, New York, New York 10013, United States of America 11/16/2022 0 Comments Overactive Bladder Treatment Market Financial Overview, SWOT Analysis, Key Development and Forecasts Till 202711/16/2022 0 Comments Clinical Decision Support Systems Market Key Manufactures Shares, Analysis and Forecasts Till 2027Market Overview:
With a 12 percent CAGR, the Clinical Decision Support Systems (CDSS) market is estimated to reach USD 1.76 billion by 2023. Clinical decision support systems (CDSS) are an essential component of the healthcare IT spectrum. Breakthrough technological developments encourage CDSS adoption, which enables speedier decision-making, data management, and enhanced workflow competency in inpatient care. The adjustable functions of this system are playing a significant role in boosting Clinical Decision Support Systems Market Share trends. The COVID-19 epidemic has created new hurdles in the healthcare ecosystem. Hospitals and health systems are dealing with massive influxes of critically sick patients as well as personnel shortages and capacity constraints. However, doctors are now better equipped with the information and abilities gained during the pandemic's early stages to develop the ideas. The increased usage of clinical decision support software in COVID-19 has emphasized the global need for comparable healthcare data while shortening the duration of decision-making owing to unprecedented stress. Many health care providers have changed their clinical decision support system vendors to promptly communicate desired outcomes. As a result, many of the world's major healthcare facilities, which are among the first responders, have a greater understanding of the usefulness and challenges of clinical decision support systems to discover new ideas for the company and for the future market. As a result, there is a need for clinical decision assistance in forms that make pertinent data easily accessible. Workflow integration is expected to emphasize market expansion in the future. Competitive Landscape Some of the key players in the global clinical decision support system are Meditech, Cerner Corporation, Carestream, Elsevier B.V., Wolters Kluwer Health, Agfa-Gevaert Group, Athenahealth, Inc, Epic Systems Corporation, Allscripts, Hearst health and others. Market Segmentation: It is expected that the software segment will grow rapidly. By Product: During the projection period, the integrated variant category is expected to gain traction. By knowledge: The knowledge-based CDSS is expected to acquire market share as a result of increased efficiency in fast-paced workplaces. The cloud sector has more potential since it provides more scalability throughout the predicted period. Regional Classification: Because of the region's cutting-edge healthcare computerised decision support system industry, North American clinical decision support businesses are expected to lead the worldwide market. The technical advancement in the healthcare industry in North America has been consistent due to the presence of several key firms in the region, resulting in access to various progressive models of clinical decision support systems. The region's rising healthcare expenditure is expected to drive the clinical decision support systems market in the future. Industry News: The clinical decision support systems market is dominated by some competitors worldwide. The Americas is a significant company's center, earning maximum market share and transforming this area into a well-established market. These firms have also extended their operational units to other locations. Furthermore, additional small and medium-sized firms profit from the local market. Wolters Kluwer Health, Allscripts, Meditech, Athenahealth, Inc, Cerner Corporation, Elsevier B.V., Hearst Health, Carestream, Epic Systems Corporation, and Agfa-Gevaert Group are important competitors in the worldwide clinical decision support system market. In 2017, the top four businesses were Meditech, Cerner Corporation, Epic Systems Corporation, and Allscripts, which accounted for almost 60% of the overall clinical decision support systems market. About US: Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street,5Th Floor, New York, New York 10013, United States of America 11/16/2022 0 Comments Minimally Invasive Cosmetic Procedures Market Key Manufactures Shares, Analysis and Forecasts Till 2027According to the MRFR reports, the global minimally invasive cosmetic procedures market is projected to attain a valuation of USD 8,400.33 million by 2027 while registering a healthy CAGR of over 8.68% during the review timeframe.
Minimally invasive surgeries refer to making small incisions on the body. The global market for these procedures has been witnessing massive growth over the years owing to the factors such as effective marketing strategies by key players, rising healthcare expenditures, the growing medical tourism industry, increasing demand for minimally invasive cosmetic surgery, and a rising number of product launches and approvals. However, the market growth is anticipated to be hampered by the complications related to cosmetic procedures and unfavorable reimbursement scenarios. Segment Analysis The global minimally invasive cosmetic procedures market is divided into several segments based on products, procedures, application, end-user, and region. Based on product, the global market is divided into microdermabrasion products, botulinum toxins, hair removal lasers, and others. Based on procedures, the minimally invasive cosmetic procedures market is split into microdermabrasion, laser hair removal, chemical peel, soft tissue fillers, botulinum toxins, and others. The minimally invasive cosmetic procedures market is divided into applications such as adipose tissue regeneration, hyperpigmentation, trauma scars, acne, etc. The global market is bifurcated into dermatology clinics, hospitals, and others based on end-users. Competitive Analysis The global Minimally-Invasive Cosmetic Procedures Market share offers both existing and new players lucrative. The market has an intensely competitive landscape with many players spread worldwide. The players worldwide adopt the latest strategies such as product development, research, partnerships, mergers, and several others to strengthen their market position. The list of prominent players across the global market includes Cutera, Inc. (U.S.), New Shining Image L.L.C. (U.S.), Advanced Microderm Inc. (U.S.), Altair Instruments (U.S.), The Procter & Gamble Company (U.S.), Lasertec Medical Services (Ireland), Dermaglow (U.S.), Silhouet-Tone Corporation (Canada), Koninklijke Philips N.V. (Netherlands), AbbVie Inc. (U.S.), and several others. Recent Developments
The Minimally Invasive Cosmetic Surgery market is studied across four major regions, including Asia-Pacific, Europe, North America, and the Rest of the World. The North American regional market has dominated the field globally in 2020 with a contribution of over 34% and is projected to exhibit a CAGR of over 9.18% during the review timeframe. The market's growth is attributed to a high number of cosmetic surgeons and the high popularity of cosmetic procedures. The European region is anticipated to grow significantly over the review timeframe and display a CAGR of 7.90%. The regional market's growth is given the presence of key companies in the region, growing popularity of minimally invasive cosmetic procedures, and higher number of patients. The Asia-Pacific region is likely to be the highest growing region globally over the coming years. The region's growth is attributed to factors such as the high percentage of the old-age population, growing demand for aesthetic procedures, and growing cosmetic expenditures. About US: Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street,5Th Floor, New York, New York 10013, United States of America |